The FIRST and ONLY transparent AI predictive of embryo viability now capable of assessing oocyte quality for:Learn More
Fairtility powers IVF through transparent artificial intelligence (AI) that may improve outcomes. Reduce the number of IVF cycles to live birth, minimize the emotional, physical and financial burden on prospective parents, and enable collaborative discussions between clinicians and patients. Welcome to the new frontier of IVF data.
Blastocyst prediction accuracy of 96% and implantation prediction accuracy of 73%1
Provides IVF professionals and patients with visibility into the clinical and laboratory parameters data output to help improve IVF outcomes
Fully automated and accurate embryonic development stage annotations validated in clinical practice
Clinically validated on over 50,000 embryos with known outcomes from over a dozen clinics world wide
1 H.K. Yelke, G. Ozkara, B. Yuksel, Y. Kumtepe Colakoglu, M. Aygun, A. Brualla, I. Erlich, C. Hickman, S. Selimoglu, B. Okten, S. Kahraman. (2022) Simplifying the complexity of time-lapse decisions with AI: CHLOE (Fairtility) can automatically annotate morphokinetics and predict blastulation (at 30hpi), pregnancy and ongoing clinical pregnancy. ESHRE Annual Meeting, O-007
Chloe turns the black box into a glass box. This is critical when AI intersects with human life.
We are world-class scientists, opinion leaders, seasoned entrepreneurs, and IVF veterans. We are parents and IVF patients. At Fairtility, we proudly face the challenge and responsibility of bringing technology to life.